10:02 AM EDT, 03/11/2026 (MT Newswires) -- Michael J. Farrell, Director, Chairman and CEO, on March 09, 2026, sold 4,991 shares in Resmed ( RMD ) for $1,252,902. Following the Form 4 filing with the SEC, Farrell has control over a total of 468,313 common shares of the company, with 466,223 shares held directly and 2,090 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/943819/000094381926000016/xslF345X05/form4.xml

Price: 238.34, Change: -8.77, Percent Change: -3.55